Kybella Approval History
- FDA approved: Yes (First approved April 29th, 2015)
- Brand name: Kybella
- Generic name: deoxycholic acid
- Dosage form: Injection
- Previous name: ATX-101
- Company: Allergan plc
- Treatment for: Submental Fullness
Kybella (deoxycholic acid) is a cytolytic drug indicated to improve the appearance of fullness associated with submental fat (double chin).
Development History and FDA Approval Process for Kybella
|Apr 29, 2015||FDA Approves Kybella (deoxycholic acid) to Treat Submental Fullness, or 'Double Chin'|
|Mar 9, 2015||Kythera Biopharmaceuticals Announces FDA Advisory Committee Unanimously Recommends to Approve ATX-101|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.